Table 1. Dataset details.
Data-Set ID | Disease | Source | GEO accession number | Seq. method | Micro-dissected | Compartment | N | Control type |
---|---|---|---|---|---|---|---|---|
1 | MCD | Internal | N.A. | NGS | Yes | Glomeruli | 22 | Healthy control |
2 | MN | Internal | N.A. | NGS | Yes | Glomeruli | 20 | Healthy control |
3 | HT | Internal | N.A. | NGS | No | N.A. | 12 | Healthy control |
4 | DIA2 | Internal | N.A. | NGS | No | N.A. | 12 | Healthy control |
5 | Fabry | Internal | N.A. | NGS | Yes | Glomeruli | 16 | Healthy control |
6 | Fabry | Internal | N.A. | NGS | Yes | Arteries | 16 | Healthy control |
7 | Fabry | Internal | N.A. | NGS | Yes | Proximal tubule | 16 | Healthy control |
8 | Fabry | Internal | N.A. | NGS | Yes | Distal Tubule | 16 | Healthy control |
9 | MN | ERCB | N.A. | MA | Yes | Glomeruli | 69 | Healthy control |
10 | MCD | ERCB | N.A. | MA | Yes | Glomeruli | 62 | Healthy control |
11 | MN | Neptune | N.A. | MA | Yes | Glomeruli | 55 | Healthy control |
12 | MCD | Neptune | N.A. | MA | Yes | Glomeruli | 54 | Healthy control |
13 | Fabry | Internal | N.A. | NGS | Yes | Glomeruli | 16 | Healthy control |
14 | Fabry | Internal | N.A. | NGS | Yes | Arteries | 16 | Healthy control |
15 | Fabry | Internal | N.A. | NGS | Yes | Proximal tubule | 16 | Healthy control |
16 | Fabry | Internal | N.A. | NGS | Yes | Distal Tubule | 16 | Healthy control |
17 | MN | Internal | N.A. | NGS | Yes | Glomeruli | 26 | MCD |
18 | MN_PLA2R_neg | Internal | N.A. | NGS | Yes | Glomeruli | 12 | MN_PLA2R_pos |
19 | RPGN | GEO | GSE104954 | MA | Yes | Tubulointerstitial | 39 | Healthy control |
20 | MCD | GEO | GSE104954 | MA | Yes | Tubulointerstitial | 26 | Healthy control |
21 | FSGS | GEO | GSE104954 | MA | Yes | Tubulointerstitial | 25 | Healthy control |
22 | DIA | GEO | GSE104954 | MA | Yes | Tubulointerstitial | 25 | Healthy control |
23 | DIA | GEO | GSE104954 | MA | Yes | Tubulointerstitial | 30 | HT |
24 | HT | GEO | GSE104954 | MA | Yes | Tubulointerstitial | 52 | Lupus |
25 | DIA | GEO | GSE104954 | MA | Yes | Tubulointerstitial | 35 | IGAN |
26 | HT | GEO | GSE104948 | MA | Yes | Glomeruli | 42 | Healthy control |
27 | IgA | GEO | GSE104948 | MA | Yes | Glomeruli | 42 | Healthy control |
28 | TCMR | GEO | GSE120495 | NGS | No | N.A. | 10 | STA |
29 | ATI | GEO | GSE120495 | NGS | No | N.A. | 10 | STA |
30 | IFTA | GEO | GSE120495 | NGS | No | N.A. | 10 | STA |
MCD: Minimal change disease, MN: Membranous nephropathy, HT: Hypertension, DN: Diabetes type 2, FSGS; Focal segmental glomerulosclerosis, IGAN; IgA nephropathy, TCMR: t-cell mediated rejection, RPGN; Rapidly progressive glomerulonephritis, STA: stable allograft, ATI: acute tubular injury, IFTA: Interstitial fibrosis and tubular atrophy. GEO; Gene Expression Omnibus, NGS: Next generation sequencing, MA: Microarray